At the international trade fair for pharmaceutical outsourcing, the International Contract Services Expo (ICSE) in Paris from 5-7 October, the Haupt Pharma Group, one of the largest pharmaceutical contract manufacturers and developers in Europe, presents its extensive portfolio of services at stand 4A14 in hall 4, which ranges from pharmaceutical development including clinical trials, through contract manufacturing, packaging and distribution.

With their trade fair presentation Haupt Pharma is demonstrating the dynamic development of the company. “We are looking forward to interesting international innovations and developments, as well as the exchange of views and information within the industry during this important trade fair. Here, Haupt Pharma are showing state-of-the-art technology and production processes,” says Karl Heinz Brücher, CTOO at Haupt Pharma.

“Only recently the fifth successfully completed inspection of one of our sites (Italy) by the US Food and Drug Administration (FDA) confirmed that our plants and the skills of our team meet the highest international standards.”

At the ICSE Haupt Pharma will also be presenting the latest systems, such as the new production plant for solids containing sex hormones at the Münster site. With respect to the production of highly active substances, this fulfils the latest FDA requirements and can therefore be used for corresponding US products.